![](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
2
Bearish Moving Averages
14
Back Stocks profile
Open Price
21.30Prev. Close
21.2900Volume
40416.00Value
849140.16Market Cap
42.00
Price to Earnings
112.80
Price to Book Value
1.90
Dividend Yield
0.00
PE to Growth
-1.50
Op Revenue TTM
13.65
Net Profit TTM
0.37
Cash From Operating Activity
2.90
Return on Equity %
1.85
EMA & SMA
Bullish Moving Averages
2
Bearish Moving Averages
14
DELIVERY AND VOLUME
05 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
21.87
Second Resistance
22.72
Third Resistance
23.46
First Support
20.28
Second Support
19.54
Third Support
18.69
Relative Strength Index
47.49
Money Flow Index
62.06
MACD
-0.04
MACD Signal
0.01
Average True Range
1.35
Average Directional Index
9.99
Rate of Change (21)
-2.78
Rate of Change (125)
-2.1
Commodity Channel Index
-44.6
Williams %R
-68.4
BETA
1 Month
0.15
3 Month
-0.51
1 Year
-0.12
3 Year
-0.09
PRICE CHANGE ANALYSIS
1 Week
Low
High
20.4
21.99
1 Month
Low
High
20
23.2
3 Months
Low
High
18
23.62
6 Months
Low
High
18
30.1
1 Year
Low
High
13.6
30.1
Veerhealth Care Limited - 511523 - Closure of Trading Window
Intimation of Closure of Trading WindowVeerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed Investors Presentation on the Audited Financial Results for the quarter and year ended 31st March, 2024.Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
In continuation of the letter dated June 08, 2024 related to the Investor Conference Call to discuss the Financial Results for the Quarter ended March 31, 2024 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the Transcripts of the Company''s Investor Call.Veerhealth Care Limited - 511523 - 'Ayuveer' Products Now Available On Nykaa For Purchase
We are delighted to announce that our brand Ayuveer''s products have successfully completed the onboarding process on Nykaa''s mobile application and website.Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
With reference to our letter dated June 08, 2024 related to the Investor Conference Call and pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and Guidance note issued by the Stock Exchange dated July 29, 2022, we hereby inform you that the audio call recording of the Company''s Investor Call to discuss the Financial Results for the Quarter ended March 31, 2024 is available on the website of the Company www.veerhealthcare.net. The link to access the said audio recording is: https://veerhealthcare.net/wp-content/uploads/2024/06/Earning-Concall-Audio-of-Veerhealth-Care-Limited-Q4-FY24.mp3 Mr. Bhavin Shah, Managing Director and Mr. Akash Shah, Chief Financial Officer were the Management attendees. It is further confirmed that no unpublished price sensitive information was shared/discussed in the meeting / call.Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Management team of the Company shall be participating in Q4 FY23-24 earnings call scheduled on Wednesday, June 12, 2024 at 2.00 pm (IST) hosted by Kirin Advisors. Please find attached details of the invitation.Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 Of SEBI LODR - Appointment Of Internal And Secretarial Auditor
Please find attached herewith the details under Regulation 30 of SEBI LODR for appointment of Internal and Secretarial Auditor.Veerhealth Care Limited - 511523 - Results-Financial Results For March 31, 2024
Please find attached Audited Financial Results for the quarter and year ended 31st March, 2024.Veerhealth Care Limited - 511523 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. May 30, 2024 as under: 1. The Board has approved and taken on record Audited Financial Results for the quarter and year ended March 31, 2024. 2. To conserve resources of the Company, the Board has not recommended any dividend on equity shares of the Company for the financial year ended March 31, 2024. The Board Meeting commenced at 4.00 p.m. and concluded at 5.00 p.m.Veerhealth Care Limited - 511523 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2024.The latest market price of Veerhealth Care Ltd. on NSE was Rs. 21.01 as of today.
The opening share price of Veerhealth Care Ltd. was Rs. 21.30 as of today.
The 52-week high share price of Veerhealth Care Ltd. was Rs. 30.10.
The 52 week low share price of Veerhealth Care Ltd. was Rs. 13.60.
The PE ratio of Veerhealth Care Ltd. is -1.50. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest bonus issue declared by Veerhealth Care Ltd. was as of 2023-09-22. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Veerhealth Care Ltd. was as of 2005-09-28. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Veerhealth Care Ltd..